Market Closed -
Japan Exchange
10:45:11 03/06/2024 am IST
|
5-day change
|
1st Jan Change
|
1,048
JPY
|
+0.38%
|
|
+0.19%
|
+4.80%
|
Fiscal Period: March |
2022
|
2023
|
---|
Capitalization
1 |
2,502
|
2,518
|
Enterprise Value (EV)
1 |
6,632
|
6,232
|
P/E ratio
|
8.63
x
|
12.1
x
|
Yield
|
1.69%
|
2.96%
|
Capitalization / Revenue
|
0.13
x
|
0.11
x
|
EV / Revenue
|
0.34
x
|
0.28
x
|
EV / EBITDA
|
9.33
x
|
7.47
x
|
EV / FCF
|
-
|
2,02,68,236
x
|
FCF Yield
|
-
|
0%
|
Price to Book
|
0.78
x
|
0.75
x
|
Nbr of stocks (in thousands)
|
2,487
|
2,489
|
Reference price
2 |
1,006
|
1,012
|
Announcement Date
|
27/06/22
|
28/06/23
|
Fiscal Period: March |
2022
|
2023
|
---|
Net sales
1 |
19,510
|
22,249
|
EBITDA
1 |
711
|
834
|
EBIT
1 |
187
|
191
|
Operating Margin
|
0.96%
|
0.86%
|
Earnings before Tax (EBT)
1 |
533
|
347
|
Net income
1 |
291
|
209
|
Net margin
|
1.49%
|
0.94%
|
EPS
2 |
116.6
|
83.84
|
Free Cash Flow
|
-
|
307.5
|
FCF margin
|
-
|
1.38%
|
FCF Conversion (EBITDA)
|
-
|
36.87%
|
FCF Conversion (Net income)
|
-
|
147.13%
|
Dividend per Share
2 |
17.00
|
30.00
|
Announcement Date
|
27/06/22
|
28/06/23
|
Fiscal Period: March |
2021 S1
|
2022 S1
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
8,059
|
8,523
|
5,488
|
10,931
|
5,602
|
5,475
|
10,993
|
5,893
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
49
|
111
|
-13
|
7
|
31
|
-26
|
24
|
253
|
Operating Margin
|
0.61%
|
1.3%
|
-0.24%
|
0.06%
|
0.55%
|
-0.47%
|
0.22%
|
4.29%
|
Earnings before Tax (EBT)
1 |
68
|
128
|
-75
|
-53
|
-5
|
-48
|
-39
|
243
|
Net income
1 |
37
|
82
|
-52
|
-44
|
-14
|
-39
|
-32
|
149
|
Net margin
|
0.46%
|
0.96%
|
-0.95%
|
-0.4%
|
-0.25%
|
-0.71%
|
-0.29%
|
2.53%
|
EPS
2 |
15.12
|
33.18
|
-20.92
|
-17.83
|
-5.860
|
-15.87
|
-13.06
|
60.21
|
Dividend per Share
|
10.00
|
13.00
|
-
|
13.00
|
-
|
-
|
13.00
|
-
|
Announcement Date
|
11/11/20
|
09/11/21
|
10/08/22
|
09/11/22
|
08/02/23
|
09/08/23
|
09/11/23
|
08/02/24
|
Fiscal Period: March |
2022
|
2023
|
---|
Net Debt
1 |
4,130
|
3,714
|
Net Cash position
1 |
-
|
-
|
Leverage (Debt/EBITDA)
|
5.809
x
|
4.453
x
|
Free Cash Flow
|
-
|
308
|
ROE (net income / shareholders' equity)
|
-
|
6.39%
|
ROA (Net income/ Total Assets)
|
-
|
0.84%
|
Assets
1 |
-
|
24,810
|
Book Value Per Share
2 |
1,287
|
1,341
|
Cash Flow per Share
2 |
451.0
|
508.0
|
Capex
1 |
922
|
539
|
Capex / Sales
|
4.73%
|
2.42%
|
Announcement Date
|
27/06/22
|
28/06/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.80% | 16.78M | | +22.91% | 88.99B | | -23.75% | 74.82B | | +1.06% | 26.63B | | +3.92% | 17.88B | | -14.20% | 16.43B | | +2.34% | 15.77B | | +76.91% | 13.21B | | +72.91% | 13.08B | | +38.99% | 12.9B |
Other Healthcare Facilities & Services
|